Crossvault Capital Management Has Boosted Its Abbvie (ABBV) Stake; Adesa (KAR) Has 0.93 Sentiment

AbbVie Inc. (NYSE:ABBV) Logo

Crossvault Capital Management Llc increased Abbvie Inc (ABBV) stake by 49.85% reported in 2018Q4 SEC filing. Crossvault Capital Management Llc acquired 5,200 shares as Abbvie Inc (ABBV)’s stock declined 10.66%. The Crossvault Capital Management Llc holds 15,632 shares with $1.44 million value, up from 10,432 last quarter. Abbvie Inc now has $115.96B valuation. The stock increased 2.04% or $1.57 during the last trading session, reaching $78.44. About 6.22M shares traded or 8.02% up from the average. AbbVie Inc. (NYSE:ABBV) has declined 30.20% since May 15, 2018 and is downtrending. It has underperformed by 34.57% the S&P500. Some Historical ABBV News: 13/03/2018 – AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids; 05/04/2018 – Biogen and Samsung Bioepis Agree to Settlement with AbbVie Allowing Commercialization of IMRALDI™ (Adalimumab Biosimilar) in Europe; 13/03/2018 – X-Chem Announces Licensing of Two Discovery Programs to AbbVie; 09/03/2018 – $ABBV AbbVie prevails against Sandoz as two IPR patent trials against AbbVie Adalimumab patent claims are denied; 05/04/2018 – BIOGEN INC – UNDER TERMS OF AGREEMENT, BIOGEN AND SAMSUNG BIOEPIS WILL MAKE ROYALTY PAYMENTS TO ABBVIE; 11/04/2018 – Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira® (adalimumab); 15/04/2018 – MERCK SAYS KEYTRUDA SAFETY PROFILE CONSISTENT W/ PRIOR TRIALS; 09/04/2018 – STAT Plus: Pharmalittle: Novartis pays $9 billion for gene therapy company; Merck’s Keytruda scores a win; 22/03/2018 – ABBVIE INC – SAFETY DATA IN TRINITY STUDY WERE CONSISTENT WITH PREVIOUSLY REPORTED STUDIES OF ROVA-T; 07/05/2018 – AbbVie’s Mavyret Falls After 1-Wk Rise, Epclusa Advances: Hep-C

Adesa Inc (KAR) investors sentiment decreased to 0.93 in Q4 2018. It’s down -0.14, from 1.07 in 2018Q3. The ratio worsened, as 146 investment managers increased and started new equity positions, while 157 trimmed and sold positions in Adesa Inc. The investment managers in our database reported: 127.65 million shares, up from 127.00 million shares in 2018Q3. Also, the number of investment managers holding Adesa Inc in top ten equity positions increased from 5 to 6 for an increase of 1. Sold All: 34 Reduced: 123 Increased: 88 New Position: 58.

Since November 29, 2018, it had 0 buys, and 5 insider sales for $21.78 million activity. Another trade for 60,000 shares valued at $5.40 million was sold by CHASE WILLIAM J. The insider Gosebruch Henry O sold $3.82 million. 16,850 AbbVie Inc. (NYSE:ABBV) shares with value of $1.50 million were sold by GONZALEZ RICHARD A. The insider Schumacher Laura J sold $2.25 million.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie Is Undervalued – Seeking Alpha” on May 15, 2019, also Finance.Yahoo.com with their article: “MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System – Yahoo Finance” published on May 14, 2019, Seekingalpha.com published: “Building A Bulletproof Portfolio Around AbbVie – Seeking Alpha” on May 02, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “FDA finalizes guidance on interchangeable biosimilars – Seeking Alpha” published on May 13, 2019 as well as Seekingalpha.com‘s news article titled: “AbbVie: No Reason To Throw In The Towel – Seeking Alpha” with publication date: May 03, 2019.

Among 5 analysts covering AbbVie (NYSE:ABBV), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. AbbVie had 8 analyst reports since December 26, 2018 according to SRatingsIntel. As per Thursday, January 3, the company rating was downgraded by Bank of America. Piper Jaffray maintained it with “Hold” rating and $90 target in Wednesday, March 13 report. BMO Capital Markets upgraded it to “Market Perform” rating and $7900 target in Monday, April 29 report. The stock of AbbVie Inc. (NYSE:ABBV) has “Neutral” rating given on Wednesday, January 23 by UBS. The firm has “Hold” rating by Piper Jaffray given on Thursday, February 21.

Investors sentiment increased to 0.83 in Q4 2018. Its up 0.01, from 0.82 in 2018Q3. It improved, as 60 investors sold ABBV shares while 631 reduced holdings. 129 funds opened positions while 444 raised stakes. 996.27 million shares or 0.22% more from 994.12 million shares in 2018Q3 were reported. Srb Corporation invested 0.06% in AbbVie Inc. (NYSE:ABBV). Grassi Investment reported 133,435 shares. 59,433 were accumulated by Nomura. Trust Of Virginia Va has invested 0.21% of its portfolio in AbbVie Inc. (NYSE:ABBV). Illinois-based Channing Capital Mngmt Ltd Liability Corp has invested 0.29% in AbbVie Inc. (NYSE:ABBV). Hartline Invest invested 0.27% of its portfolio in AbbVie Inc. (NYSE:ABBV). Donaldson Capital has 392,635 shares. Cap City Trust Communication Fl holds 1.14% or 29,978 shares. 26,968 were accumulated by Baldwin Inv Mgmt Llc. Moreover, Sand Hill Global Advisors Ltd Liability Co has 0.03% invested in AbbVie Inc. (NYSE:ABBV) for 3,052 shares. Los Angeles Cap Mngmt And Equity Research holds 0.56% in AbbVie Inc. (NYSE:ABBV) or 971,256 shares. First Allied Advisory Services Inc reported 0.27% of its portfolio in AbbVie Inc. (NYSE:ABBV). Bellecapital Int has 3.15% invested in AbbVie Inc. (NYSE:ABBV) for 47,989 shares. Saturna Capital has 1.26% invested in AbbVie Inc. (NYSE:ABBV) for 406,577 shares. 99,141 were accumulated by Mairs Pwr.

More notable recent KAR Auction Services, Inc. (NYSE:KAR) news were published by: Seekingalpha.com which released: “KAR Auction Q1 2019 Earnings Preview – Seeking Alpha” on May 06, 2019, also Forbes.com with their article: “KAR Auctions Services Targets Spin Of Insurance Auto Auctions Spinco In 2Q – Forbes” published on April 23, 2019, Seekingalpha.com published: “Starboard’s Smith boosts KAR Auction, Cerner – Seeking Alpha” on April 16, 2019. More interesting news about KAR Auction Services, Inc. (NYSE:KAR) were released by: Prnewswire.com and their article: “KAR Auction Services, Inc. to Announce First Quarter 2019 Earnings – PRNewswire” published on April 23, 2019 as well as Benzinga.com‘s news article titled: “Earnings Scheduled For May 7, 2019 – Benzinga” with publication date: May 07, 2019.

KAR Auction Services, Inc., together with its subsidiaries, provides vehicle auction services in the United States, Canada, Mexico, and the United Kingdom. The company has market cap of $7.24 billion. It operates in three divisions: ADESA Auctions, IAA, and AFC. It has a 23.22 P/E ratio. The ADESA Auctions segment offers whole car auctions and related services to the vehicle remarketing industry through online auctions and auction facilities.

KAR Auction Services, Inc. (NYSE:KAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.